The beta adrenergic receptor antagonist propranolol alters mitogenic and apoptotic signaling in late stage breast cancer

201966 citationsJournal Articlegold Open Access

Authors

Alexa Montoya · Texas Tech University

Armando Varela‐Ramírez · The University of Texas at El Paso

Erin B. Dickerson · University of Minnesota

Eddy Pasquier · Centre National de la Recherche Scientifique

Alireza Torabi · Texas Tech University

Renato J. Aguilera · The University of Texas at El Paso

Zeina Nahleh

Abstract

Collectively, these data provide support for the incorporation of β-AR antagonists into the clinical management of breast cancer, and elucidate a partial molecular mechanism explaining the efficacy of β-AR antagonists against this disease.

Topics & Keywords

Cancer, Stress, Anesthesia, and Immune Response Neuropeptides and Animal Physiology Nanoplatforms for cancer theranostics

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Biomedical Journal

Volume 42, Issue 3, pp. 155-165

DOI: 10.1016/j.bj.2019.02.003

Field-Weighted Citation Impact: 7.07